Medifast (MED) Profit After Tax (2010 - 2026)

Medifast (MED) has 17 years of Profit After Tax data on file, last reported at -$2.1 million in Q1 2026.

• Quarterly Profit After Tax fell 174.87% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.0 million (down 186.19% YoY) and the FY2025 annual result came in at -$18.7 million, down 992.97% from the prior year.
• Profit After Tax advanced to -$2.1 million in Q1 2026, from -$18.1 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $41.8 million in Q1 2022 to a low of -$18.1 million in Q4 2025.
• A 5-year average of $13.2 million and a median of $6.0 million in 2023 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 130.41% in 2025, down 2362.05% in 2025.
• Tracing MED's Profit After Tax over 5 years: stood at $26.5 million in 2022, then tumbled by 77.24% to $6.0 million in 2023, then tumbled by 86.73% to $801000.0 in 2024, then slumped by 2362.05% to -$18.1 million in 2025, then soared by 88.29% to -$2.1 million in 2026.
• The last three Profit After Tax figures came in at -$2.1 million (Q1 2026), -$18.1 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.